This invention relates to the fields of
microbial genetic engineering and
fermentation biomanufacturing technology, specifically disclosing a recombinant
Corynebacterium glutamicum with high 5-aminolevulinic acid (ALA) production and its applications. Addressing the problems of existing strains such as crude
enzyme activity regulation, inhibited
cell growth, the need for external inhibitors, and low yield, this invention uses
Corynebacterium glutamicum as a host and removes the gdhA
gene without scarring to reduce precursor competitive
metabolism. Site-directed mutations of the endogenous hemB
gene (S288A, D128E, R231K) are performed to moderately reduce
dehydratase activity. A high-expression
plasmid pXMJ19-hemA containing the hemA
gene from Rhodopsinus capsulatum is constructed and introduced into the modified strain to obtain a recombinant strain with optimized triple
metabolism. This strain reduces product degradation without the need for external
dehydratase inhibitors, does not affect
cell growth, and achieves a yield up to 4.30 times higher than the control after 42 hours of
fermentation, with ALA accumulation exceeding 8.9 g / L. The strain exhibits stable characteristics, the process is simple, and it has good industrial application value.